Research
Print page Print page
Switch language
  1. Rigshospitalet
  2. Publications
  3. Lymphoblastic Lymphoma
  4. Citationformats
Rigshospitalet - a part of Copenhagen University Hospital
Published

Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Dabaja, BS, Specht, L & Yahalom, J 2018, 'Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)' International Journal of Radiation Oncology Biology Physics, vol. 102, no. 3, pp. 508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

APA

Dabaja, B. S., Specht, L., & Yahalom, J. (2018). Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology Biology Physics, 102(3), 508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

CBE

Dabaja BS, Specht L, Yahalom J. 2018. Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology Biology Physics. 102(3):508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

MLA

Dabaja, Bouthaina Shbib, Lena Specht and Joachim Yahalom. "Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)". International Journal of Radiation Oncology Biology Physics. 2018, 102(3). 508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

Vancouver

Dabaja BS, Specht L, Yahalom J. Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology Biology Physics. 2018 Nov 1;102(3):508-514. https://doi.org/10.1016/j.ijrobp.2018.05.078

Author

Dabaja, Bouthaina Shbib ; Specht, Lena ; Yahalom, Joachim. / Lymphoblastic Lymphoma : Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). In: International Journal of Radiation Oncology Biology Physics. 2018 ; Vol. 102, No. 3. pp. 508-514.

Bibtex

@article{855a6d78e20e46f6a6aacf058e890c45,
title = "Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)",
abstract = "Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.",
author = "Dabaja, {Bouthaina Shbib} and Lena Specht and Joachim Yahalom",
note = "Copyright {\circledC} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.ijrobp.2018.05.078",
language = "English",
volume = "102",
pages = "508--514",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc",
number = "3",

}

RIS

TY - JOUR

T1 - Lymphoblastic Lymphoma

T2 - Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

AU - Dabaja, Bouthaina Shbib

AU - Specht, Lena

AU - Yahalom, Joachim

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.

AB - Presentation with a large mediastinal mass is a hallmark of acute lymphoblastic lymphoma, a disease that is treated in the same way as acute lymphoblastic leukemia even in the absence of marrow involvement. The role of mediastinal radiation for patients who achieve complete remission after chemotherapy has been overlooked and controversial. This document presents current knowledge on the role of radiation for lymphoblastic lymphoma and best practices for addressing how to deliver mediastinal radiation with modern technology.

U2 - 10.1016/j.ijrobp.2018.05.078

DO - 10.1016/j.ijrobp.2018.05.078

M3 - Review

VL - 102

SP - 508

EP - 514

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -

ID: 55856737